All stock lists
Deutsche Bank AG (New York Stock Exchange:DB)
DE · Delayed Price · Currency is USD
Also listed: DBK.DE, DBK.SWFinancial Services · Banks - Regional
$36.62-$0.03 (-0.08%)
Market cap
$67.9B
Insider Score
Health Score
Analyst consensus
Listed since
Nov 18, 1996
Website
Insider Score
––Not scored
DB Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From DB’s reported statements · Q3 2026 (trailing 12 months)
Profitability17 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $53.59B
- Net income
- $7.24B
- Net margin
- 13.5%
Leverage18 / 20
Little or no net debt.
- Total debt
- $148.97B
- Cash
- $145.04B
- Net debt / EBITDA
- 0.38x
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $376.42B
- Current liabilities
- $935.22B
- Current ratio
- 0.40
Cash generation11 / 20
Roughly cash-neutral.
- Operating cash flow
- $0
- Free cash flow
- $0
- FCF margin
- 0.0%
Dilution & runway12 / 20
Some dilution over the past year.
- Shares outstanding
- 2152.3M
- Share growth (1y)
- 10.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
DB Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $15.51 B | $15.07 B | $15.29 B | $7.73 B | $15.08 B | $15.03 B |
| Revenue Growth (YoY) | 2.84 % | 0.29 % | -6.61 % | -49.39 % | -9.11 % | -12.77 % |
| Cost of Revenue | $7.84 B | $7.06 B | $7.14 B | $395.00 M | $7.47 B | $7.63 B |
| Gross Profit | $7.67 B | $8.02 B | $8.15 B | $7.33 B | $7.61 B | $7.40 B |
| SG&A Expense | $2.95 B | $3.10 B | $5.11 B | $2.95 B | $5.18 B | $4.96 B |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $5.10 B | $5.33 B | $5.11 B | $5.30 B | $5.16 B | $4.98 B |
| Operating Income | $2.58 B | $2.68 B | $3.04 B | $2.03 B | $2.44 B | $2.42 B |
| Pretax Income | $2.58 B | $2.68 B | $3.04 B | $2.03 B | $2.44 B | $2.42 B |
| Tax Provision | $762.47 M | $774.00 M | $867.00 M | $453.00 M | $626.00 M | $688.00 M |
| Net Income | $1.77 B | $1.85 B | $2.12 B | $1.50 B | $1.77 B | $1.69 B |
| EPS (Basic) | $0.82 | $0.58 | $0.84 | $0.67 | $0.80 | $1.00 |
| EPS (Diluted) | $0.80 | $1.10 | $0.82 | $0.65 | $0.78 | $0.74 |
| Shares Outstanding | 2.15 B | 2.18 B | 1.93 B | 1.94 B | 1.96 B | 1.97 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.